The agreements mean the remaining claims against the Swiss maker of generic drugs in the U.S. generic antitrust litigation are those from individual plaintiffs.
Source link
Sandoz to Pay Around $480 Million to Settle U.S. Antitrust Pricing Litigations
Date:
More like thisRelated
Senate Democrats block Sen. Husted-led bill on data centers, calling it ‘toothless’
WASHINGTON — Senate Democrats blocked legislation Wednesday aimed at...
UK says there are ‘strong indications’ Iran played a part in security incident at US-run air base
UK says there are 'strong indications' Iran played a...
Something Was Stolen From Ella Langley’s ‘Choosin’ Texas’ Set
Don't go calling the cops or anything... but it...